(Date:5/12/2008)...2 /PRNewswire-USNewswire/ -- Baptist Health South,...n Miami, has agreed to,pay the United States $7,77...Claims Act and the Stark Statute between 2003 and ...ogy group that was a source of patient,referrals t...stice,announced today. The payments were made purs...
(Date:5/12/2008)...h., May 12 /PRNewswire-USNewswire/ -- Michael A.,S...st, was installed as,president of the 15,000 membe... 143rd annual meeting of the MSMS House of Delegat...ne State University School of Medicine, Doctor,San...ic Radiology at Henry,Ford Hospital and currently ...
(Date:5/12/2008)... NASDAQ: CRME TSX: COM, VANCOUVER, May 12 /P...AQ: CRME / TSX: COM) today announced that it will ...2008 on the afternoon of Tuesday, May 13,2008. Ca... at 4:30pm,Eastern (1:30pm Pacific) on that day to...all, please dial 416-641-6117 or,866-299-6655. The...
(Date:5/12/2008)...lif., May 12 /PRNewswire-FirstCall/ -- MAP,Pharmac...nancial results for,the first quarter ended March ...ed March 31, 2008 was $14.3,million compared with ...,March 31, 2008, MAP Pharmaceuticals had cash, cas...million., First Quarter Financial Results, Resea...
Breaking Medicine News(10 mins):Health News:Florida Hospital Group Pays U.S. $7,775,000 to Settle False Claims Act Allegations 2Health News:Michael A. Sandler, MD, Installed as President of Michigan State Medical Society 2Health News:Cardiome To Release 2008 First Quarter Results 2Health News:Cardiome To Release 2008 First Quarter Results 3Health News:Cardiome To Release 2008 First Quarter Results 4Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 2Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 3Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 4Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 5... the University of Missouri-Columbia; is of the vi...ld be a good source for cattle feed. In his stud... at the College of Agriculture, is examining the e...n as cattle feed. Through November, Kerley will ...
...uths to learn meditation from Indian spiritual gur...visit to the war-hit country Thursday with a trip ...of Living Foundation, Iraqi Youth Minister Jasin M...hree youths from each province of Iraq to Bangalor...
...hrax in Orissa's tribal dominated Koraput district... the last two days, health officials said Friday.... 35, of Padiguda village under Semliguda block in ... Bhubaneswar, fell to the disease reportedly after...
...m Friday urge the nation's doctors to work for rur...t-Graduate Institute of Medical Sciences in Rohtak...ties available for village India. If each doctor ...t at least 20 rural patients a year, the president...
Other Medicine News:Health News:Study Finds Glycerin to Be a Good Source for Cattle Feed 2Health News:Art of Living Foundation to Train Iraqi Youths 2(Date:5/12/2008)...NTA, May 12 /- GeoVax Labs,...d HIV/AIDS vaccine development,company, announced ...n,stock purchase agreement with Fusion Capital Fun..., The Company may sell up to $10 million of its c...er a 25-month period after the Securities and,Exch...
(Date:5/12/2008)...ides the Optimal Combination of Scaffolding, Deliv...bility, TEL AVIV, Israel, May 12 /- ...CE Mark for its Presillion(TM) CoCr Coronary Stent...ions with a technologically,innovative flexible cl... the superb scaffolding the unprecedented,balance ...
(Date:5/12/2008)...ADELPHIA, May 12 /PRNewswire-USNewswire/ -- GlaxoS...International Group (BIG), a leading,academic brea...groups, the,Spanish Breast Cancer Cooperative Grou...hase III study that will examine the role of TYKER...ALTTO (Neoadjuvant Lapatinib and/or,Trastuzumab Tr...
(Date:5/9/2008)..., Fla., May 9 /PRNewswire-USNewswire/ -- Osteoarth...ndition that affects almost 50,million people in t...,cartilage in bone joints. The novel investigation...oral analgesic, provided significant relief,for pa...treated with,placebo, and with fewer gastrointesti...
Breaking Medicine Technology:GeoVax Secures $10 Million Financing Commitment 2GeoVax Secures $10 Million Financing Commitment 3Medinol Receives CE Mark for Presillion(TM) Cobalt Chromium Coronary Stent on Rx System, an Advanced Evolution of the NIR(R) Family of Stents 2TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 2TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 3TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 4TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 5TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 6TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 7Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5Friends of Warren Zevon To Play at Maverick Saloon Raising Awareness of Asbestos Cancer Mesothelioma 5200 1Friends of Warren Zevon To Play at Maverick Saloon Raising Awareness of Asbestos Cancer Mesothelioma 5200 2West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 1West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 2West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 3West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 4West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 5West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 6West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 7West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 8West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 9West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 10West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 11West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 12West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 13West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 14West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 15West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 16West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 17United Therapeutics Reports Third Quarter 2007 Financial Results 1642 1United Therapeutics Reports Third Quarter 2007 Financial Results 1642 2United Therapeutics Reports Third Quarter 2007 Financial Results 1642 3United Therapeutics Reports Third Quarter 2007 Financial Results 1642 4United Therapeutics Reports Third Quarter 2007 Financial Results 1642 5United Therapeutics Reports Third Quarter 2007 Financial Results 1642 6United Therapeutics Reports Third Quarter 2007 Financial Results 1642 7United Therapeutics Reports Third Quarter 2007 Financial Results 1642 8United Therapeutics Reports Third Quarter 2007 Financial Results 1642 9Neurocrine Biosciences and Dainippon Sumitomo Pharma 28DSP 29 Announce Agreement to Develop and Commercialize Indiplon in Japan 1640 1Neurocrine Biosciences and Dainippon Sumitomo Pharma 28DSP 29 Announce Agreement to Develop and Commercialize Indiplon in Japan 1640 2Neurocrine Biosciences and Dainippon Sumitomo Pharma 28DSP 29 Announce Agreement to Develop and Commercialize Indiplon in Japan 1640 3...HTS, N.J.--(BUSINESS WIRE)--Jun 28, 2007 - Cyclace...CP) announced today,the results from two Phase II ...mbinations. In one study seliciclib was given in,c...nother with,docetaxel in patients with advanced no...ectives of the studies were to assess the safety,a...
...rted From Three NCI-Sponsored Clinical Trials , SO...,Incorporated (Nasdaq: CYTK) announced results fr...of ispinesib administered as,monotherapy, one in p...s with melanoma, and one in patients with hormone-...mall molecule inhibitor of,kinesin spindle protein...
Other Medicine Technology:Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib,Combination Studies 2Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib,Combination Studies 3Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 2Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 3Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 4Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 5Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 6Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 7Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 8The design and concept of the Alpina knee allows the choice of implanting a PCL retaining or a posterior stabilized prosthesis intraoperatively, right up until the definitive implants are to be put i
Tibial distractor
...werSuite™ holmium laser combines excellent c...ecise, virtually bloodless procedures. It is also ...l bladder stones of all compositions, making it an...er light is transmitted through flexible fibers, i...
...werSuite™ holmium laser combines excellent c...ecise, virtually bloodless procedures. It is also ...l bladder stones of all compositions, making it an...er light is transmitted through flexible fibers, i...
Medicine Products: